Genetic Disorders Drug Market is Anticipated to Increase at a Stable CAGR over the Forecast Period (2023 to 2029)

Genetic Disorders Drug Market is anticipated to grow at a significant CAGR during the forecast period. A genetic disorder is a disease that is caused by a change in the DNA sequence. It is caused by a mutation in one gene or by mutations in multiple genes or by a combination of gene mutations and environmental factors and by damage to chromosomes. The major factor for the growth of the global genetic disorders drug market is the increasing genetic disorders across the globe. According to the Genetic and Rare Diseases Information Center (GARD), an estimated 25-30 million people are living with a genetic disorder in the US. Furthermore, the global genetic disorders drugs is growing owing to new FDA approvals. For instance, in May 2019, AveXis Inc. announced that they received the approval for Zolgensma (onasemnogene abeparvovec-xioi) From the US FDA. It is the first gene therapy used for the treatment of spinal muscular atrophy (SMA) in children less than two years of age.

Some major players in the market include Novartis International AG, Sanofi SA, and Pfizer Inc., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in June 2021, ProMetic Biotherapeutics Inc. announced the approval of Ryplazim (plasminogen, human-tvmh) from the US FDA. It is used for the treatment of plasminogen deficiency type 1, a disorder that can impair normal tissue and organ function and may lead to blindness.

To Request a Sample of our Report on Genetic Disorders Drug Market: https://www.omrglobal.com/request-sample/genetic-disorders-drug-market

Market Coverage

• The market number available for - 2022-2030

• Base year- 2022

• Forecast period- 2022-2030

Segment Covered-

· By Type

· By Application

Regions Covered-

· North America

· Europe

· Asia-Pacific

· Rest of the World

Competitive Landscape- Novartis International AG, Sanofi SA, and Pfizer Inc., among others.

Genetic Disorders Drug Market Report by Segment

By Type

• Single Gene Disorders

• Chromosome Disorders

• Multifactorial Disorders

• Others

By Application

• Hospital

• Clinics

• Others

A full Report of Genetic Disorders Drug Market is Available @ https://www.omrglobal.com/industry-reports/genetic-disorders-drug-market

Genetic Disorders Drug Market Report by Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

· Latin America

· Middle East & Africa

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.